You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ipilimumab

Showing 1 - 25 of 914
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Soft-tissue Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • (no location specified)
May 26, 2023

Melanoma, Hepatocellular Carcinoma (HCC), Renal Cell Carcinoma (RCC) Trial (INCB 99280 with Ipilimumab)

Not yet recruiting
  • Melanoma
  • +5 more
  • INCB 99280 with Ipilimumab
  • (no location specified)
Jun 9, 2023

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Nivolumab
  • +5 more
  • (no location specified)
Aug 21, 2023

Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)

Completed
Has Results
  • Melanoma
  • Skin Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023

Pancreatic Cancer Trial in Herlev (drug, radiation, biological)

Not yet recruiting
  • Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Feb 8, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Portland (Intratumoral Ipilimumab)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Intratumoral Ipilimumab
  • Portland, Oregon
    Portland Providence Medical Center
Jan 8, 2023

Cervical Cancer = FIGO IIB and or Lymph Node Metastases Trial (Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab),

Not yet recruiting
  • Cervical Cancer ≥ FIGO IIB and or Lymph Node Metastases
  • Pre-Chemo-radio-immunotherapy Treatment (Nivolumab/Ipilimumab)
  • +2 more
  • (no location specified)
Aug 16, 2022

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

Recruiting
  • Glioblastoma
  • +3 more
  • Nivolumab-Placebo
  • +4 more
  • Los Angeles, California
  • +3 more
Jan 16, 2023

Solid Tumor, Solid Tumor, Adult Trial (Sargramostim, Ipilimumab-containing therapy)

Suspended
  • Solid Tumor
  • Solid Tumor, Adult
  • Sargramostim
  • Ipilimumab-containing therapy
  • Lexington, Massachusetts
    Partner Therapeutics - No Currently Active Sites
Nov 30, 2022

IDH1-mutant Cholangiocarcinoma Trial (Ivosidenib, Recommended Combination Dose (RCD) of ivosidenib, Nivolumab)

Not yet recruiting
  • IDH1-mutant Cholangiocarcinoma
  • (no location specified)
Jun 29, 2023

Melanoma Trial in Aurora (VESANOID, Ipilimumab)

Active, not recruiting
Has Results
  • Melanoma
  • Aurora, Colorado
    University of Colorado Hospital
Sep 7, 2022

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma Trial (Nivolumab, Ipilimumab, Surgical Procedure)

Not yet recruiting
  • Pleural Biphasic Mesothelioma
  • Pleural Sarcomatoid Mesothelioma
  • Nivolumab
  • +5 more
  • (no location specified)
Dec 9, 2022

Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,

Not yet recruiting
  • Metastatic Extraskeletal Myxoid Chondrosarcoma
  • +3 more
  • Biopsy
  • +6 more
  • (no location specified)
Apr 25, 2023

Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Tampa, Florida
  • +1 more
Nov 11, 2022

Prostate Cancer Trial in London (Nivolumab & Ipilimumab)

Active, not recruiting
  • Prostate Cancer
  • Nivolumab & Ipilimumab
  • London, United Kingdom
    University College London Hospital
Sep 26, 2022

Cutaneous Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab, Ipilimumab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Amsterdam, Noord Holland, Netherlands
    NKI-AVL
Oct 24, 2022

Non Small Cell Lung Cancer Trial in Providence (Ipilimumab, Nivolumab, SBRT)

Recruiting
  • Non Small Cell Lung Cancer
  • Ipilimumab
  • +2 more
  • Providence, Rhode Island
    Rhode Island Hospital
Jan 26, 2023

Breast Cancer Trial in Boston, Pittsburgh, Dallas (Nivolumab, Ipilimumab)

Active, not recruiting
Has Results
  • Breast Cancer
  • Boston, Massachusetts
  • +2 more
Oct 21, 2022

Mucinous Tumor, Colorectal Tumor, Appendiceal Tumor Trial in Philadelphia (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Mucinous Adenocarcinoma of the Colon
  • Mucinous Adenocarcinoma of the Rectum
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Sep 26, 2022

NSCLC Trial in Amsterdam (Ipilimumab, Cemiplimab, SBRT)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Ipilimumab
  • +2 more
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoek - Netherlands Cancer Institute
Jan 10, 2023

Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8 Trial

Not yet recruiting
  • Metastatic Nasopharyngeal Carcinoma
  • +2 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jun 13, 2023

Metastatic Castration Sensitive Prostate Cancer Trial in New York (Degarelix, Ipilimumab, Radical Prostatectomy)

Active, not recruiting
  • Metastatic Castration Sensitive Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 4, 2022

Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 6, 2022

Melanoma Trial in Tampa (Ipilimumab, Axitinib)

Recruiting
  • Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Jun 21, 2022

Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)

Recruiting
  • Metastatic Melanoma
  • Metastasis to Brain
  • Tampa, Florida
  • +1 more
Jan 30, 2023